The COVID-19 pandemic has led to understandable anxiety within the blood cancer community about how their illness may affect their ability to overcome COVID-19 infection. Members of the Oxford Centre for Haematology have led a collaborative research project looking at the response of patients ... READ MORE
News
Lowering blood pressure still beneficial for the heart in old age
Oxford University researchers have found that blood pressure medication is still effective at reducing the risk of a heart attack and stroke in old age, even if blood pressure is in an apparently healthy range. The research by Professor Kazem Rahimi, who is supported by the NIHR Oxford ... READ MORE
New study launched to understand vaccine escape
Oxford researchers will be involved in a major new study seeking to understand why some people become infected after vaccination or prior infection while others do not Oxford BRC-supported investigators already involved in the Protective Immunity from T-Cells in Healthcare workers (PITCH) study ... READ MORE
Vaccination still best protection, but less effective against Delta variant, study finds
The latest findings of an ongoing national study of COVID-19 immunity in households across the UK has found that the Pfizer-BioNTech and Oxford-AstraZeneca vaccines offer good protection against new infections of the Delta variant of concern, but that effectiveness is reduced compared with the Alpha ... READ MORE
Second study confirms benefits of budesonide in early stages of COVID-19
A UK-wide clinical study has confirmed the findings of an earlier Oxford BRC-supported study showing that the early treatment with the inhaled asthma medication budesonide speeds up recovery from COVID-19 and reduces the risk of hospitalisation and death. The latest study – part of the PRINCIPLE ... READ MORE
Consultation on the draft NIHR Oxford Biomedical Research Centre Patient and Public Involvement and Engagement Strategy (2022-2027)
We are undertaking a public consultation on the draft Oxford Biomedical Research Centre (BRC) Patient and Public Involvement and Engagement (PPIE) Strategy (2022-2027). The consultation runs until 12th September 2021. In order to hear views from a diverse range of people, we ... READ MORE
First person receives drug designed to re-sensitise patients to cancer treatment
The first patient has been dosed using a new drug aimed at improving treatment options for melanoma and non-small cell lung cancer (NSCLC) and re-sensitising patients with checkpoint therapy-resistant tumours The IMP-MEL clinical trial began in Oxford with its first patient being dosed with the ... READ MORE
BRC-supported study receives Best Research Paper Award
A leading cardiology journal has named an academic paper written by Oxford BRC-supported researchers as its best research paper of 2020. The paper – which found that two common heart medication do not increase the risk of COVID-19 hospitalisation – was named by the BMJ Heart journal as the ... READ MORE
Oxford BRC takes part in NIHR initiative to promote race equality in health research
The Oxford Biomedical Research Centre (BRC) is to take part in a three-month reflective assessment of its delivery of race equality in health research, starting this month. The initiative, led by the NIHR, involved 13 organisations delivering health research in higher education, local ... READ MORE
Context important in assessing gender equity in BRCs
A study by NIHR Oxford Biomedical Research Centre researchers has concluded that the markers of achievement for monitoring gender equity in BRCs should take into account contextual factors specific to BRCs and women’s career progression and professional advancement. The study, published as a ... READ MORE
- « Previous Page
- 1
- …
- 28
- 29
- 30
- 31
- 32
- …
- 95
- Next Page »